Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 3 | 2024 | 190 | 1.670 |
Why?
|
| Portoenterostomy, Hepatic | 3 | 2024 | 49 | 1.510 |
Why?
|
| Bile Acids and Salts | 3 | 2025 | 244 | 1.000 |
Why?
|
| Infant Formula | 1 | 2024 | 96 | 0.870 |
Why?
|
| Liver Transplantation | 4 | 2021 | 1037 | 0.810 |
Why?
|
| Child Development | 1 | 2025 | 266 | 0.780 |
Why?
|
| Milk, Human | 1 | 2024 | 300 | 0.750 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2025 | 702 | 0.670 |
Why?
|
| Microbiota | 1 | 2020 | 389 | 0.480 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2024 | 59 | 0.390 |
Why?
|
| End Stage Liver Disease | 1 | 2014 | 181 | 0.390 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 290 | 0.370 |
Why?
|
| Cholestasis | 2 | 2022 | 154 | 0.350 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 2 | 2021 | 22 | 0.340 |
Why?
|
| Purpura | 2 | 2021 | 24 | 0.340 |
Why?
|
| Infant | 7 | 2025 | 12514 | 0.300 |
Why?
|
| Clostridium Infections | 2 | 2021 | 245 | 0.260 |
Why?
|
| Liver | 3 | 2025 | 1747 | 0.200 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2024 | 302 | 0.200 |
Why?
|
| Alagille Syndrome | 1 | 2022 | 47 | 0.190 |
Why?
|
| Vancomycin | 1 | 2024 | 220 | 0.190 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2022 | 56 | 0.190 |
Why?
|
| Disease Resistance | 1 | 2021 | 23 | 0.190 |
Why?
|
| Hypertension, Portal | 1 | 2021 | 78 | 0.170 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 130 | 0.170 |
Why?
|
| Bile | 1 | 2020 | 46 | 0.170 |
Why?
|
| Treatment Outcome | 5 | 2024 | 12392 | 0.160 |
Why?
|
| Liver Diseases | 1 | 2022 | 367 | 0.150 |
Why?
|
| Organoids | 1 | 2021 | 281 | 0.150 |
Why?
|
| Graft Rejection | 1 | 2021 | 590 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 577 | 0.140 |
Why?
|
| Stem Cells | 1 | 2021 | 707 | 0.130 |
Why?
|
| Humans | 14 | 2025 | 125186 | 0.130 |
Why?
|
| Child | 7 | 2025 | 24418 | 0.120 |
Why?
|
| Biomarkers | 3 | 2022 | 3091 | 0.120 |
Why?
|
| Child, Preschool | 4 | 2025 | 14026 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1898 | 0.110 |
Why?
|
| Stroke | 1 | 2021 | 989 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 188 | 0.100 |
Why?
|
| Age Factors | 2 | 2021 | 2823 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2014 | 228 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3573 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2431 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 152 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8232 | 0.090 |
Why?
|
| Cytokines | 1 | 2017 | 1288 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2014 | 494 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2013 | 309 | 0.090 |
Why?
|
| Budesonide | 1 | 2009 | 19 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 339 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 2998 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2022 | 209 | 0.080 |
Why?
|
| Eosinophils | 1 | 2009 | 118 | 0.080 |
Why?
|
| Sinusitis | 1 | 2009 | 116 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2009 | 101 | 0.070 |
Why?
|
| Male | 6 | 2024 | 61523 | 0.070 |
Why?
|
| Female | 6 | 2024 | 66803 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 293 | 0.070 |
Why?
|
| Adolescent | 5 | 2024 | 19362 | 0.060 |
Why?
|
| Risk Factors | 2 | 2021 | 10316 | 0.060 |
Why?
|
| Remission Induction | 1 | 2024 | 300 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 21 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 21 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 2913 | 0.050 |
Why?
|
| Pruritus | 1 | 2022 | 41 | 0.050 |
Why?
|
| Butyrates | 1 | 2022 | 35 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 684 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2022 | 101 | 0.050 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.050 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2021 | 48 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2021 | 82 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2021 | 157 | 0.040 |
Why?
|
| Time | 1 | 2021 | 92 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2021 | 257 | 0.040 |
Why?
|
| Internationality | 1 | 2021 | 132 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2019 | 8 | 0.040 |
Why?
|
| Graft Survival | 1 | 2021 | 538 | 0.040 |
Why?
|
| Stomach | 1 | 2021 | 270 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 115 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 383 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1420 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 228 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2017 | 43 | 0.040 |
Why?
|
| Glucosyltransferases | 1 | 2017 | 49 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 119 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 832 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1897 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3056 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 420 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2067 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 505 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 1435 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4817 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3744 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 6336 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4262 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2009 | 180 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4645 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 16353 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 1197 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 1396 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 5845 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 17631 | 0.010 |
Why?
|
| Helicobacter pylori | 1 | 2013 | 1324 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 6153 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 34230 | 0.010 |
Why?
|
| United States | 1 | 2013 | 10914 | 0.010 |
Why?
|